Vascular Biogenics Ltd.
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-7.11-1.91-7.17-7.56-19.45-1.56-2.17-3.39-4.75-0.28-1.33-19.45
Price/Sales ratio
N/AN/AN/AN/A14.2254.6676.6189.51177.8314.1415.0614.22
Price/Book Value ratio
-5.230.943.052.853.520.601.202.662.610.410.570.60
Price/Cash Flow ratio
-9.40-2.42-8.09-9.02-51.62-2.03-3.39-3.53-5.46-0.29-0.33-51.62
Price/Free Cash Flow ratio
-9.38-2.41-8.03-8.71-19.14-1.78-3.37-3.52-5.16-0.28-0.32-19.14
Price/Earnings Growth ratio
0.16-0.010.090.610.46-0.020.19-1.860.17-0.11-0.00-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A97.54%59.82%70.99%57.26%52.47%84.19%76.69%76.69%
Operating Profit Margin
N/AN/AN/AN/A-76.85%-3625.12%-3561.21%-2655.42%-3905.72%-4992.85%-4913.93%-3625.12%
Pretax Profit Margin
N/AN/AN/AN/A-73.12%-3497.09%-3462.09%-2627.44%-3895.83%-4909.42%-1130.67%-1130.67%
Net Profit Margin
N/AN/AN/AN/A-73.12%-3497.09%-3517.79%-2638.82%-3738.02%-4896.50%-1130.67%-1130.67%
Effective Tax Rate
-8.11%-15.10%-0.11%1.70%5.09%3.66%-1.60%-0.43%4.05%0.26%N/A3.66%
Return on Assets
-146.86%-45.64%-37.94%-33.84%-15.43%-33.71%-40.66%-58.33%-44.39%-108.63%-32.55%-32.55%
Return On Equity
73.65%-49.58%-42.52%-37.74%-18.13%-38.53%-55.16%-78.69%-55.01%-143.50%-28.75%-28.75%
Return on Capital Employed
-210.49%-41.97%-42.39%-38.30%-18.33%-37.93%-50.16%-71.48%-54.80%-143.28%-183.02%-37.93%
Liquidity Ratios
Current Ratio
N/A12.889.289.727.7210.834.324.28N/AN/A3.2910.83
Quick Ratio
2.6512.919.159.677.6810.834.254.105.573.092.6210.83
Cash ratio
2.2012.551.702.410.886.141.081.762.212.622.620.88
Days of Sales Outstanding
N/AN/AN/AN/A88.11325.06408.51127.47220.99N/AN/A325.06
Days of Inventory outstanding
N/AN/AN/AN/A302.73N/A1.34K1.26K-4654.61KN/AN/A
Operating Cycle
N/AN/AN/AN/A390.85325.061.75K1.39K-244.004.61KN/A325.06
Days of Payables Outstanding
N/AN/AN/AN/A3.28K1.85K7.45K1.81K4.33K2.83KN/A1.85K
Cash Conversion Cycle
N/AN/AN/AN/A-2.89K-1.52K-5.70K-422.80-4.57K1.77KN/A-2.89K
Debt Ratios
Debt Ratio
2.62N/AN/AN/AN/A0.010.060.060.030.010.240.24
Debt Equity Ratio
-1.31N/AN/AN/AN/A0.010.080.080.040.020.320.32
Long-term Debt to Capitalization
4.16N/AN/AN/AN/A0.000.050.060.03N/AN/A0.00
Total Debt to Capitalization
4.16N/AN/AN/AN/A0.010.070.070.040.02N/A0.01
Interest Coverage Ratio
N/AN/A-127.10N/AN/AN/A-63.94-233.17N/AN/A-608.18N/A
Cash Flow to Debt Ratio
-0.42N/AN/AN/AN/A-19.69-4.31-9.24-10.62-56.01N/AN/A
Company Equity Multiplier
-0.501.081.121.111.171.141.351.341.231.321.321.17
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-0.27-26.80-22.59-25.35-32.53-48.01-44.76-26.80
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.001.032.691.141.001.001.051.021.031.14
Cash Flow Coverage Ratio
-0.42N/AN/AN/AN/A-19.69-4.31-9.24-10.62-56.01N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-45.18-16.40-46.84-47.22-56.01N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A